M&T Bank
NKTR icon

M&T Bank’s Nektar Therapeutics NKTR Stock Holding History

M&T Bank’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-69
Closed -$18.6M – 1651
2020
Q1 		$18.6M Buy
+69
New +$21.3K 0.11% 165
2018
Q4 		– Sell
-372
Closed -$340K – 1520
2018
Q3 		$340K Buy
+372
New +$318K ﹤0.01% 1180
2014
Q4 		– Sell
-786
Closed -$142K – 2200
2014
Q3 		$142K Buy
+786
New +$150K ﹤0.01% 1966

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

M&T Bank's NKTR Position: Q2 2020 in Review

M&T Bank sold out of Nektar Therapeutics (NKTR) in Q2 2020, closing a stake of 69 shares — an estimated $18.6M sold.

M&T Bank first reported a position in NKTR in Q3 2014 and held it in 3 quarters. The position peaked at $18.6M in Q1 2020. 260 funds tracked by Wall St. Rank hold NKTR as of Q2 2020.

  • M&T Bank reported no remaining Nektar Therapeutics position as of Q2 2020 after selling out during the quarter.
  • M&T Bank sold 69 Nektar Therapeutics shares in Q2 2020, an estimated $18.6M.
  • M&T Bank first reported a position in Nektar Therapeutics in Q3 2014 and held it in 3 quarters.
  • M&T Bank's Nektar Therapeutics position peaked at $18.6M in Q1 2020.
  • 260 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2020.

Based on M&T Bank's 13F filing for Q2 2020, filed 29 Jul 2020.